Skip to main content
55th ASAM Annual Conference Main banner
Final Program


Conference Program
Back

Michelle Lofwall, MD, DFAPA, DFASAM

Professor of Behavioral Science & Psychiatry, Medical Director of First Bridge & Straus Clinics
University of Kentucky College of Medicine, Center on Drug and Alcohol Research, Kentucky

Dr. Michelle Lofwall is a Professor in the Departments of Behavioral Science and Psychiatry and the Bell Alcohol and Addictions Endowed Chair at the University of Kentucky (UK). She is the medical director of UK’s Robert Straus and First Bridge Clinics, which provide comprehensive opioid use disorder (OUD) treatment within the UK Center on Drug and Alcohol Research. Her passion is in improving the care of patients with addiction including in special populations such as pregnant and parenting persons. Her research has included evaluation of novel treatments for opioid use disorder (e.g., buprenorphine implants and depot injections), understanding factors associated with buprenorphine diversion, improving care delivery of complex patients with OUD, and best practices for linking and retaining persons in care for OUD treatment. She was elected as a Distinguished Fellow of American Society of Addiction Medicine (ASAM) and the American Psychiatric Association. She has received numerous teaching and mentoring awards, the Nyswander/Dole (Marie) Award from the American Association for the Treatment of Opioid Dependence and was an expert panel member for SAMHSA’s Treatment Improvement Protocol on Medication Treatment for Opioid Use Disorder (TIP 63).

Presentation(s):